Open AccessThe target antigen determines the mechanism of acquired resistance to T cell-based therapies
Author(s) -
Alex Martínez-Sabadell,
Beatriz Morancho,
Irene Rius Ruiz,
Macarena Román Alonso,
Pablo Ovejero Romero,
Marta Escorihuela,
Irene Chicote,
Héctor G. Pálmer,
Lara ll,
Mercè Alemany-Chavarria,
Christian Klein,
Marina Bacac,
Joaquı́n Arribas,
Enrique J. Arenas
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.111430
Subject(s) - immunotherapy , antigen , cancer research , cancer , acquired resistance , cancer immunotherapy , mechanism (biology) , medicine , immunology , t cell , tumor antigen , biology , immune system , philosophy , epistemology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom